Search Results - "Heijnen, V V"

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours by Aapro, M.S, Bohlius, J, Cameron, D.A, Lago, Lissandra Dal, Donnelly, J. Peter, Kearney, N, Lyman, G.H, Pettengell, R, Tjan-Heijnen, V.C, Walewski, J, Weber, Damien C, Zielinski, C

“…Abstract Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and also a significant dose-limiting toxicity in…”
Get full text

Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases by de Boer, M., van Dijck, J. A. A. M., Bult, P., Borm, G. F., Tjan-Heijnen, V. C. G.

“…Background The prognostic relevance of isolated tumor cells and micrometastases in lymph nodes from patients with breast cancer has become a major issue since…”
Get full text

Factors related to patient-reported cosmetic outcome after breast-conserving therapy for breast cancer by Brands-Appeldoorn, A. T. P. M., Thomma, R. C. M., Janssen, L., Maaskant-Braat, A. J. G., Tjan-Heijnen, V. C. G., Roumen, R. M. H.

“…Background Multiple factors can affect cosmetic outcome after breast-conserving therapy. We investigated which combination of factors could optimally predict…”
Get full text

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? by Lobbezoo, D J A, van Kampen, R J W, Voogd, A C, Dercksen, M W, van den Berkmortel, F, Smilde, T J, van de Wouw, A J, Peters, F P J, van Riel, J M G H, Peters, N A J B, de Boer, M, Peer, P G M, Tjan-Heijnen, V C G

“…Background: We aimed to determine the prognostic impact of time between primary breast cancer and diagnosis of distant metastasis (metastatic-free interval,…”
Get full text

Population‐based study of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ by Keymeulen, K. B. I. M., Geurts, S. M. E., Lobbes, M. B. I., Heuts, E. M., Duijm, L. E. M., Kooreman, L. F. S., Voogd, A. C., Tjan‐Heijnen, V. C. G.

“…Background Determinants of the use of breast MRI in patients with ductal carcinoma in situ (DCIS) in the Netherlands were studied, and whether using MRI…”
Get full text

Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD by Gulikers, J. L., Veelen, A. J., Driessen, J. H. M., Souverein, P. C., Tjan‐Heijnen, V. C. G., Hendriks, L. E. L., Geel, R. M. J. M., Croes, S.

“…Introduction In recent years, the number of general practices contributing to the Clinical Practice Research Datalink (CPRD) database GOLD is decreasing…”
Get full text

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer by Truin, W., Vugts, G., Roumen, R. M. H., Maaskant-Braat, A. J. G., Nieuwenhuijzen, G. A. P., van der Heiden-van der Loo, M., Tjan-Heijnen, V. C. G., Voogd, A. C.

“…Background This study was conducted to determine the impact of neoadjuvant chemotherapy (NAC) on the likelihood of breast-conserving surgery (BCS) performed…”
Get full text

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08) by van Roozendaal, L M, Vane, M L G, van Dalen, T, van der Hage, J A, Strobbe, L J A, Boersma, L J, Linn, S C, Lobbes, M B I, Poortmans, P M P, Tjan-Heijnen, V C G, Van de Vijver, K K B T, de Vries, J, Westenberg, A H, Kessels, A G H, de Wilt, J H W, Smidt, M L

“…Studies showed that axillary lymph node dissection can be safely omitted in presence of positive sentinel lymph node(s) in breast cancer patients treated with…”
Get full text

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07) by van Roozendaal, L M, de Wilt, J H W, van Dalen, T, van der Hage, J A, Strobbe, L J A, Boersma, L J, Linn, S C, Lobbes, M B I, Poortmans, P M P, Tjan-Heijnen, V C G, Van de Vijver, K K B T, de Vries, J, Westenberg, A H, Kessels, A G H, Smidt, M L

“…Trials failed to demonstrate additional value of completion axillary lymph node dissection in case of limited sentinel lymph node metastases in breast cancer…”
Get full text

Local recurrence following breast-conserving treatment in women aged 40 years or younger: Trends in risk and the impact on prognosis in a population-based cohort of 1143 patients by van Laar, C, van der Sangen, M.J.C, Poortmans, P.M.P, Nieuwenhuijzen, G.A.P, Roukema, J.A, Roumen, R.M.H, Tjan-Heijnen, V.C.G, Voogd, A.C

“…Abstract Aim To evaluate trends in the risk of local recurrences after breast-conserving treatment (BCT) and to examine the impact of local recurrence (LR) on…”
Get full text

The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions by Beugels, J., Meijvogel, J. L. W., Tuinder, S. M. H., Tjan-Heijnen, V. C. G., Heuts, E. M., Piatkowski, A., van der Hulst, R. R. W. J.

“…Purpose The impact of neoadjuvant chemotherapy on the surgical outcomes of immediate breast reconstruction remains controversial. The aim of this study was to…”
Get full text

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review by Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., Wildberger, J. E.

“…Objectives This systematic review aimed to assess the role of magnetic resonance imaging (MRI) in evaluating residual disease extent and the ability to detect…”
Get full text

Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review by Prevos, R., Smidt, M. L., Tjan-Heijnen, V. C. G., van Goethem, M., Beets-Tan, R. G., Wildberger, J. E., Lobbes, M. B. I.

“…Objectives To assess whether magnetic resonance imaging (MRI) can identify pre-treatment differences or monitor early response in breast cancer patients…”
Get full text

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET) by Jerusalem, G., Mariani, G., Ciruelos, E.M., Martin, M., Tjan-Heijnen, V.C.G., Neven, P., Gavila, J.G., Michelotti, A., Montemurro, F., Generali, D., Simoncini, E., Lang, I., Mardiak, J., Naume, B., Camozzi, M., Lorizzo, K., Bianchetti, S., Conte, P.

“…This European phase IIIb, expanded-access multicenter trial evaluated the safety of EVE plus EXE in a patient population similar to BOLERO-2. Post-menopausal…”
Get full text

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours by Aapro, M.S., Cameron, D.A., Pettengell, R., Bohlius, J., Crawford, J., Ellis, M., Kearney, N., Lyman, G.H., Tjan-Heijnen, V.C., Walewski, J., Weber, D.C., Zielinski, C.

“…Chemotherapy-induced neutropenia is not only a major risk factor for infection-related morbidity and mortality, but is also a significant dose-limiting…”
Get full text

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands by Ruiterkamp, J., Ernst, M. F., de Munck, L., van der Heiden-van der Loo, M., Bastiaannet, E., van de Poll-Franse, L. V., Bosscha, K., Tjan-Heijnen, V. C. G., Voogd, A. C.

“…In this study, changes in prognosis for more than 8,000 patients with primary distant metastatic breast cancer were analyzed, using nation-wide data of the…”
Get full text

Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer by Van Baelen, K, Geukens, T, Maetens, M, Tjan-Heijnen, V, Lord, C J, Linn, S, Bidard, F-C, Richard, F, Yang, W W, Steele, R E, Pettitt, S J, Van Ongeval, C, De Schepper, M, Isnaldi, E, Nevelsteen, I, Smeets, A, Punie, K, Voorwerk, L, Wildiers, H, Floris, G, Vincent-Salomon, A, Derksen, P W B, Neven, P, Senkus, E, Sawyer, E, Kok, M, Desmedt, C

“…Invasive lobular breast cancer (ILC) is the second most common type of breast cancer after invasive breast cancer of no special type (NST), representing up to…”
Get full text

Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners by Gietel-Habets, J.J.G., de Die-Smulders, C.E.M., Derks-Smeets, I.A.P., Tibben, A., Tjan-Heijnen, V.C.G., van Golde, R., Gomez-Garcia, E., Kets, C.M., van Osch, L.A.D.M.

“…Abstract STUDY QUESTION To what extent are BRCA mutation carriers and their partners in the Netherlands aware about preimplantation genetic diagnosis (PGD) and…”
Get full text

Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis by Verheuvel, N. C., Voogd, A. C., Tjan-Heijnen, V. C. G., Siesling, S., Roumen, R. M. H.

“…Background Evidence and consensus is lacking in international guidelines regarding axillary treatment recommendations for patients in whom a sentinel lymph…”
Get full text

Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial by Wintraecken, V.M., Boersma, L.J., van Roozendaal, L.M., de Vries, J., van Kuijk, S.M.J., Vane, M.L.G., van Dalen, T., van der Hage, J.A., Strobbe, L.J.A., Linn, S.C., Lobbes, M.B.I., Poortmans, P.M.P, Tjan-Heijnen, V.C.G., van de Vijver, K.K.B.T., Westenberg, A.H., de Wilt, J.H.W., Smidt, M.L., Simons, J.M.

“…•In the BOOG 2013-08 trial, RT-protocol adherence was 98.5%.•Patients in a subanalysis received a mean breast dose of ≥95% of the prescribed dose.•The majority…”
Get full text